{"organizations": [], "uuid": "2a440dcaf5607aeebb82dd79079891f182288da6", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-fda-accepts-new-drug-application-f/brief-fda-accepts-new-drug-application-for-duvelisib-and-grants-priority-review-idUSASC09V7B", "country": "US", "domain_rank": 408, "title": "BRIEF-FDA Accepts New Drug Application For Duvelisib And Grants Priority Review", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-09T10:02:00.000+03:00", "replies_count": 0, "uuid": "2a440dcaf5607aeebb82dd79079891f182288da6"}, "author": "", "url": "https://www.reuters.com/article/brief-fda-accepts-new-drug-application-f/brief-fda-accepts-new-drug-application-for-duvelisib-and-grants-priority-review-idUSASC09V7B", "ord_in_thread": 0, "title": "BRIEF-FDA Accepts New Drug Application For Duvelisib And Grants Priority Review", "locations": [], "entities": {"persons": [{"name": "duvelisi", "sentiment": "negative"}], "locations": [], "organizations": [{"name": "fda", "sentiment": "none"}, {"name": "verastem inc", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 9, 2018 / 7:04 AM / Updated 39 minutes ago BRIEF-FDA Accepts New Drug Application For Duvelisib And Grants Priority Review Reuters Staff \nApril 9 (Reuters) - Verastem Inc: \n* FDA ACCEPTS NEW DRUG APPLICATION FOR DUVELISIB AND GRANTS PRIORITY REVIEW \n* ‍FDA TARGET ACTION DATE IS OCTOBER 5, 2018​ Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-04-09T10:02:00.000+03:00", "crawled": "2018-04-09T10:54:05.001+03:00", "highlightTitle": ""}